APLLTD - Swing Trade Analysis with AI Signals
← Back to ListKey Parameters
⭐ Swing Trade Rating: 3.8
✅ Positive
APLLTD demonstrates strong recent profitability growth with a significant quarter-over-quarter PAT increase of 249%. The company also exhibits healthy financial ratios including a reasonable Debt to Equity ratio and positive ROCE and ROE metrics. Furthermore, the PEG Ratio of 0.86 suggests the stock is currently undervalued relative to earnings growth.
⚠️ Limitation
Despite solid recent performance, the stock's valuation is high as indicated by its P/E ratio of 22.5, which is above the industry average. The negative changes in FII and DII holdings alongside a relatively high RSI of 46.4 could signal potential selling pressure.
📉 Company Negative News
None found
📈 Company Positive News
None found
🏭 Industry
The pharmaceutical sector remains attractive due to ongoing demand for generic drugs and increasing healthcare spending globally, particularly with Alembic Pharmaceuticals securing USFDA approval for a key product. However, competition within the industry is fierce, and regulatory hurdles can significantly impact company performance.
🧾 Conclusion
An optimal entry price would be around 785 ₹ based on current levels and considering the positive growth trend. To exit, consider a target of 840 ₹ representing a modest upside potential. Overall, APLLTD presents a moderate swing trading opportunity due to its recent momentum and favorable industry backdrop; however, traders should remain cautious regarding valuation concerns and monitor market sentiment.